Login   |  Users Online: 2670 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Search Article 
  
Advanced search 
   Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts


 
  Table of Contents  
LETTER TO EDITOR
Year : 2011  |  Volume : 32  |  Issue : 3  |  Page : 432  

Mehamudgaravati and type 2 diabetes mellitus


Visiting Professor, Hainan Medical University, China; Wiwanitkit House, Bangkhae, Bangkok, Thailand 10160

Date of Web Publication17-Mar-2012

Correspondence Address:
Viroj Wiwanitkit
Visiting Professor, Hainan Medical University, China; Wiwanitkit House, Bangkhae, Bangkok, Thailand 10160

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-8520.93929

Rights and Permissions

How to cite this article:
Wiwanitkit V. Mehamudgaravati and type 2 diabetes mellitus. AYU 2011;32:432

How to cite this URL:
Wiwanitkit V. Mehamudgaravati and type 2 diabetes mellitus. AYU [serial online] 2011 [cited 2019 Nov 17];32:432. Available from: http://www.ayujournal.org/text.asp?2011/32/3/432/93929

Sir,

The recent publication on Mehamudgaravati and type 2 diabetes mellitus is very interesting. [1] Tanna et al., concluded that this drug is useful due to "its known hypolipidemic, hypocholesterolemic, hepatoprotective, antihyperglycemic, antistress, antioxidant and immunomodulatory activities. [1]" I have some comments on this work. First, the authors tried to investigate on some parameters. Many parameters are subjective and can be biased. Focussing on laboratory investigation, there is no quality control information. The simple fasting blood sugar can be affected by several interferences and a single measurement might not be a reliable parameter for decision on improvement of diabetes mellitus. Finally, the authors did not investigate on lipid, antioxidant and immunity; hence, the conclusion on those aspects cannot be made.

 
   References Top

1.Tanna I, Chandola HM, Joshi JR. Clinical efficacy of Mehamudgaravati in type 2 diabetes mellitus. Ayu 2011;32:30-9.  Back to cited text no. 1
  Medknow Journal  




 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References

 Article Access Statistics
    Viewed1099    
    Printed61    
    Emailed0    
    PDF Downloaded207    
    Comments [Add]    

Recommend this journal